Connecticut
Prescription drug spending and prescribing in Connecticut, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $4.1B for prescriptions written in Connecticut, the 26th most of 52 states and territories, and 2.8% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $4.1B
- Medicaid drugs, 2025: $2.0B
- Opioid share of claims: 2.8%
- Life-science raises, 2 years: $506M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Connecticut | United States | Difference |
|---|---|---|---|
| Opioids | 2.8% | 3.5% | -21% |
| Antibiotics | 4.2% | 4.4% | -5% |
| Antipsychotics | 2.2% | 1.7% | +28% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Connecticut's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Fluoride (Sodium) | 3.1× | 17,319 |
| Molnupiravir | 2.5× | 6,035 |
| Clozapine | 2.3× | 31,636 |
| Vibegron | 2.1× | 33,419 |
| Amlodipine Bes/Olmesartan Med | 2.1× | 8,565 |
| Sodium, Potassium,mag Sulfates | 2.1× | 22,434 |
| Hydromorphone Hcl | 2.0× | 18,848 |
| Latanoprostene Bunod | 2.0× | 6,919 |
| Cefpodoxime Proxetil | 2.0× | 12,210 |
| Bromfenac Sodium | 1.9× | 5,911 |
Biggest Medicaid Drugs
What Connecticut's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
52 Form D raises by companies based in Connecticut in the last two years; the 10 largest. See all raises- Veradermics, Inc$135M · Other health care · Oct 28, 2025
- VeraDermics, Inc$67M · Other health care · Dec 10, 2024
- Oxbridge Health, Inc.$39M · Other health care · Aug 20, 2026
- Triton Therapeutics, Inc.$36M · Pharma · Oct 23, 2025
- Veradermics, Inc$30M · Other health care · May 15, 2026
- Allyx Therapeutics, Inc.$28M · Biotech · May 11, 2026
- Quarry Glue Holding Co LLC$20M · Biotech · Nov 18, 2025
- Cloverleaf Bio, Inc.$15M · Biotech · Sep 9, 2026
- Quarry Heme, Inc$14M · Biotech · Feb 25, 2026
- Convexity Scientific Inc.$10M · Other health care · Aug 7, 2026
State Attorney General Health-Care Cases
Antitrust cases Connecticut joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Connecticut v. Connecticut Chiropractic Ass'n et al. (Conn. Super. Ct. Hartford March 25, 2008)2008 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG